Torrent Pharmaceuticals

Torrent Pharmaceuticals (India) holds 41 active US FDA Type II Drug Master Files and 5 inactive, has DMF or CEP filings on record for 40 active ingredients and is linked to 5 FDA-registered manufacturing sites. 17 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Torrent Pharmaceuticals: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/torrent-pharmaceuticals

Overview

Torrent Pharmaceuticals is a leading pharmaceutical company based in India, known for its wide-ranging portfolio of generic and branded drugs. The company is committed to producing high-quality healthcare solutions in various therapeutic areas to meet global healthcare needs.

Core services & business areas

ManufacturingResearch and DevelopmentRegulatory AffairsQuality Assurance

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Torrent Pharmaceuticals holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Torrent Pharmaceuticals holds 41 active (46 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • AVATROMBOPAG MALEATEActive2026-06-06
  • LEVOKETOCONAZOLEActive2025-08-30
  • VERICIGUATActive2024-11-22
  • STIRIPENTOLActive2023-12-29
  • PRUCALOPRIDE SUCCINATEActive2023-06-04
  • ZOLPIDEM TARTRATE USPActive2023-02-23
  • PENCICLOVIRActive2021-10-29
  • ROFLUMILAST USPActive2021-03-11
  • ALOGLIPTIN BENZOATEActive2020-12-11
  • FEBUXOSTATActive2020-11-02
  • SITAGLIPTIN PHOSPHATE MONOHYDRATE USPActive2018-01-19
  • SILODOSINActive2016-11-15
  • DIMETHYL FUMARATE USPActive2016-09-26
  • RASAGILINE MESYLATEActive2016-06-21
  • ANAGRELIDE HYDROCHLORIDE USPActive2015-07-13
  • GUANFACINE HYDROCHLORIDE USPActive2014-08-04
  • LURASIDONE HYDROCHLORIDEActive2014-04-22
  • ESOMEPRAZOLE MAGNESIUM TRIHYDRATE USPActive2013-10-31
  • REPAGLINIDEActive2012-01-03
  • DARIFENACIN HYDROBROMIDEActive2011-12-08
  • MONTELUKAST SODIUMActive2011-04-01
  • TELMISARTAN USPActive2011-03-25
  • OLMESARTAN MEDOXOMIL USPActive2010-09-29
  • ALFUZOSIN HYDROCHLORIDE USPActive2010-03-22
  • ESOMEPRAZOLE MAGNESIUM USPActive2009-09-14
  • NEBIVOLOL HYDROCHLORIDEActive2009-06-29
  • QUETIAPINE FUMARATEActive2009-03-30
  • CANDESARTAN CILEXETILActive2009-03-30
  • ATORVASTATIN CALCIUMActive2009-02-26
  • OLANZAPINEActive2009-02-18
  • SILDENAFIL CITRATEActive2008-10-31
  • RABEPRAZOLE SODIUM USPActive2008-06-26
  • RISPERIDONEActive2008-05-19
  • PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATEActive2008-05-19
  • DULOXETINE HYDROCHLORIDE USPActive2008-03-31
  • DONEPEZIL HYDROCHLORIDE USPActive2007-11-01
  • TOPIRAMATEActive2007-03-28
  • LAMOTRIGINE USPActive2007-02-22
  • ROPINIROLE HYDROCHLORIDE DRUG SUBSTANCEActive2005-09-14
  • VENLAFAXINE HYDROCHLORIDE USPActive2005-08-30
  • SERTRALINE HYDROCHLORIDE DRUG SUBSTANCEActive2005-04-29
  • LEVODOPAInactive2011-11-11
  • TELMISARTANInactive2010-11-11
  • PALIPERIDONEInactive2010-06-29
  • CLOPIDOGREL BISULPHATE FORM-IInactive2010-01-21
  • CLOPIDOGREL BISULPHATE FORM IIInactive2008-01-16

Registered manufacturing sites (5)

Physical sites registered with the US FDA and resolved to Torrent Pharmaceuticals, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

17 FDA enforcement records linked to this company.

  • 4832023-05-25

    Computer control of master formula records

  • 4832023-05-25

    Investigations of discrepancies, failures

  • 4832022-09-28

    Cleaning / Sanitizing / Maintenance

  • 4832022-09-28

    Written record of complaint to include findings, follow-up

  • 4832022-09-28

    Investigations of discrepancies, failures

  • warning_letter2019-10-08

    FDA Warning Letter (drug product)

  • 4832018-06-15

    Failure to develop written procedures

  • 4832018-06-15

    Periodic safety report missing ICSR

  • 4832018-06-15

    Late submission of an ICSR

  • recall — Class III2016-04-27

    Presence of Foreign Substance: Product complaint for the presence of foreign matter identified as silicone within the tablet.

  • 4832013-07-26

    Test methods

  • 4832009-04-16

    Prepared for each batch, include complete information

  • 4832009-04-16

    Scientifically sound laboratory controls

  • 4832009-04-16

    Investigations of discrepancies, failures

  • 4832009-04-16

    Written procedures not established/followed

  • 4832009-04-16

    Cleaning / Sanitizing / Maintenance

  • 4832009-04-16

    Control procedures to monitor and validate performance

For suppliers

Is this Torrent Pharmaceuticals?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.